Aytu BioPharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is July - June.

Millions GBP. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '25 May 15, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	17	14	14	7	22	91
Market Cap Growth	101.53%	3.51%	98.41%	-68.25%	-76.01%	-33.80%
Enterprise Value	11	17	13	12	17	77
Last Close Price	1.66	1.61	2.29	1.21	8.64	72.97
PS Ratio	0.37	0.30	0.27	0.12	0.28	1.92
PB Ratio	1.64	1.03	0.63	0.23	0.60	0.92
EV/Sales Ratio	0.23	0.36	0.25	0.20	0.21	1.61
EV/EBITDA Ratio	3.39	3.02	2.24	5.92	-	-
EV/EBIT Ratio	-	9.43	28.87	-	-	-
Debt / Equity Ratio	1.47	1.21	0.59	0.47	0.41	0.18
Debt / EBITDA Ratio	4.94	2.68	1.75	4.68	-	-
Asset Turnover	0.53	0.55	0.51	0.54	0.48	0.31
Inventory Turnover	2.10	1.74	1.56	2.23	3.41	2.77
Quick Ratio	0.93	0.99	0.70	0.75	0.64	0.71
Current Ratio	1.16	1.26	1.00	1.03	0.93	0.96
Return on Equity (ROE)	-109.23%	-60.76%	-37.33%	-18.05%	-119.62%	-50.12%
Return on Assets (ROA)	-0.22%	1.31%	0.28%	-2.37%	-11.81%	-11.41%
Return on Capital Employed (ROCE)	-0.70%	4.20%	1.00%	-7.70%	-52.10%	-24.50%
Earnings Yield	-104.93%	-69.30%	-90.85%	-192.92%	-408.69%	-46.22%
FCF Yield	-3.00%	-11.06%	-9.85%	-58.03%	-108.29%	-22.45%
Buyback Yield / Dilution	-38.73%	-13.40%	-65.81%	-127.22%	-75.54%	-270.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.